Skip to main content

Esade Matins with Adriana Rubio, president and CEO of Roche Diagnostics Spain 

The president and CEO of Roche Diagnostics Spain sees the management of chronic disease as one of the key future challenges facing Spain’s health system
Adriana Rubio

 

Innovation is essential for keeping people healthy. It can improve efficiency, reduce costs and shorten treatment times; enable access to healthcare by providing services in remote areas; and also better health outcomes, leading to more effective, personalized treatments,” said Adriana Rubio, president and CEO of Roche Diagnostics Spain, during her speech at a session of Esade Matins entitled “Innovative diagnostics serving people”. Rubio stressed that if innovation is to be effective, it is crucial to have a preventive mindset, infrastructures enabling access to data and diagnoses, and an open ecosystem of collaboration. “All this must be underpinned by scientific rigor, ethical principles and strict regulatory compliance,” she added.

Committed to investing in R&D

Roche Diagnostics develops innovative products and services designed to prevent, diagnose and monitor the treatment of disease. Over its more than 125-year history, Roche has become one of the world’s largest biotechnology companies, a leading provider of in-vitro diagnostics and also a global provider of transformative and innovative solutions in major therapeutic areas.

 

Adriana Rubio

 

“Roche Diagnostics invests in R&D today in order to continue making a difference tomorrow. In 2023, we earmarked 13.2 billion Swiss francs for this purpose around the globe, making us one of the main investors in R&D in healthcare,” highlighted the president and CEO of Roche Diagnostics Spain. She added that “we have more than 2,500 employees in Spain including Madrid and Sant Cugat (Barcelona) and we invest more than 500 million euros a year in innovation.” She also emphasized the key role of Catalonia “as one of the main science hubs in Europe”, in comparison with countries such as Sweden, Finland, Denmark, Ireland, Belgium and Austria in terms of funding in this sector.

Future challenges: managing chronic illness

As regards the future of healthcare, Rubio warned that “pressure on the system will increase as chronic diseases proliferate and healthcare is decentralized.” She also pointed out that “the average cost of healthcare has grown more than GDP in the last twenty years,” and expects outpatient care to increase in the next ten years. She believes that the main challenges will concern the management of chronic disease: “There’s a need for prevention and an opportunity to manage chronic disease, and this would reduce healthcare outlay.”

 

Adriana Rubio

 

You can see the video of the session at the Content Hub